Evidence map›Paper›PMID 31210100›Full record

ArticleStem cells and development2019

Transplantation of Human Embryonic Stem Cell-Derived Retinal Tissue in the Subretinal Space of the Cat Eye.

Ratnesh K Singh, Laurence M Occelli, Francois Binette, Simon M Petersen-Jones, Igor O Nasonkin

Open access · hybridAbstract read
In one paragraph

Article in Stem cells and development, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 1 synthesis or guideline pooled it, 54 citations in OpenAlex.

  1. Pooled it
  2. Incidence of and treatment strategies for giant retinal tears in cats with retinal detachment.The Canadian veterinary journal = La revue veterinaire canadienne · 2026
    Article
  3. Monitoring Gene Expression in Retina with synthetic serum markers.bioRxiv : the preprint server for biology · 2026
    Article
  4. Article
  5. Review
  6. The neuroimmune interface in retinal regeneration.Progress in retinal and eye research · 2025
    Review
  7. Animal models for the evaluation of retinal stem cell therapies.Progress in retinal and eye research · 2025
    Review
  8. Review
  9. New frontiers in retinal transplantation.World journal of transplantation · 2024
    Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Ratnesh K SinghLineage Cell Therapeutics, Inc. (formerly BioTime Inc.), Carlsbad, California.
Laurence M OccelliDepartment of Small Animal Clinical Sciences, College of Veterinary Medicine, Michigan State University, East Lasing, Michigan.
Francois BinetteLineage Cell Therapeutics, Inc. (formerly BioTime Inc.), Carlsbad, California.
Simon M Petersen-JonesDepartment of Small Animal Clinical Sciences, College of Veterinary Medicine, Michigan State University, East Lasing, Michigan.
Igor O NasonkinLineage Cell Therapeutics, Inc. (formerly BioTime Inc.), Carlsbad, California.
Lineage Cell Therapeutics (United States) · USMichigan State University · US

Funding

Retinal tissue derived from human pluripotent stem cells for vision restorationR44EY027654 · NEI · BIOTIME, INC. · PI NASONKIN, IGOR O., PETERSEN-JONES, SIMON · 2017 to 2019
$2.2M
NEI NIH HHS R44 EY027654
6 · The paper itself

Abstract

To develop biological approaches to restore vision, we developed a method of transplanting stem cell-derived retinal tissue into the subretinal space of a large-eye animal model (cat). Human embryonic stem cells (hESC) were differentiated to retinal organoids in a dish. hESC-derived retinal tissue was introduced into the subretinal space of wild-type cats following a pars plana vitrectomy. The cats were systemically immunosuppressed with either prednisolone or prednisolone plus cyclosporine A. The eyes were examined by fundoscopy and spectral-domain optical coherence tomography imaging for adverse effects due to the presence of the subretinal grafts. Immunohistochemistry was done with antibodies to retinal and human markers to delineate graft survival, differentiation, and integration into cat retina. We successfully delivered hESC-derived retinal tissue into the subretinal space of the cat eye. We observed strong infiltration of immune cells in the graft and surrounding tissue in the cats treated with prednisolone. In contrast, we showed better survival and low immune response to the graft in cats treated with prednisolone plus cyclosporine A. Immunohistochemistry with antibodies (STEM121, CALB2, DCX, and SMI-312) revealed large number of graft-derived fibers connecting the graft and the host. We also show presence of human-specific synaptophysin puncta in the cat retina. This work demonstrates feasibility of engrafting hESC-derived retinal tissue into the subretinal space of large-eye animal models. Transplanting retinal tissue in degenerating cat retina will enable rapid development of preclinical in vivo work focused on vision restoration.

Indexed as

AnimalsCalbindin 2CatsCell DifferentiationCell LineCells, CulturedCellular Reprogramming TechniquesDoublecortin Domain ProteinsDoublecortin ProteinGraft SurvivalHuman Embryonic Stem CellsHumansMicrotubule-Associated ProteinsNeuropeptidesRetinaStem Cell TransplantationCALB2 protein, humanCalbindin 2DCX protein, humanDoublecortin Domain ProteinsDoublecortin ProteinMicrotubule-Associated ProteinsNeuropeptidesSynaptophysinhuman embryonic stem cellslarge-eye animal modelsretinal organoidssubretinal transplantationsynaptic connectivityvision restoration

Identifiers

PMID31210100
PMCPMC6708274
OpenAlexW2952321987

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.